Cargando…

Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies

Thromboplasminflammation in coronavirus disease 2019 (COVID-19) coagulopathy consists of angiotensin II (Ang II)-induced coagulopathy, activated factor XII (FXIIa)- and kallikrein, kinin system-enhanced fibrinolysis, and disseminated intravascular coagulation (DIC). All three conditions induce syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gando, Satoshi, Wada, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226122/ https://www.ncbi.nlm.nih.gov/pubmed/34177896 http://dx.doi.org/10.3389/fimmu.2021.649122

Ejemplares similares

Coagulopathy Induced by Veno-Arterial Extracorporeal Membrane Oxygenation Is Associated With a Poor Outcome in Patients With Out-of-Hospital Cardiac Arrest
por: Tsuchida, Takumi, et al.
Publicado: (2021)

Activated protein C does not increase in the early phase of trauma with disseminated intravascular coagulation: comparison with acute coagulopathy of trauma-shock
por: Jesmin, Subrina, et al.
Publicado: (2016)

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
por: Thachil, Jecko, et al.
Publicado: (2020)

Investigation of the Molecular Mechanism of Coagulopathy in Severe and Critical Patients With COVID-19
por: Elieh Ali Komi, Daniel, et al.
Publicado: (2021)

Coagulopathy and Traumatic Brain Injury: Overview of New Diagnostic and Therapeutic Strategies
por: NAKAE, Ryuta, et al.
Publicado: (2022)

Sepsis-related coagulopathy treatment based on the disseminated intravascular coagulation diagnostic criteria: a post-hoc analysis of a prospective multicenter observational study
por: Wada, Takeshi, et al.
Publicado: (2023)

Hematological Phenotype of COVID-19-Induced Coagulopathy: Far from Typical Sepsis-Induced Coagulopathy
por: Umemura, Yutaka, et al.
Publicado: (2020)

Activated protein C plays no major roles in the inhibition of coagulation or increased fibrinolysis in acute coagulopathy of trauma-shock: a systematic review
por: Gando, Satoshi, et al.
Publicado: (2018)

COVID-19 and Coagulopathy
por: Inoue, Ken-ichiro, et al.
Publicado: (2021)

Coagulopathy and COVID-19
por: Lorini, Ferdinando Luca, et al.
Publicado: (2021)

Coagulopathy in COVID-19
por: Lio, Ka U, et al.
Publicado: (2021)

MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy
por: Moll, Guido, et al.
Publicado: (2020)

Association of antithrombin with development of trauma-induced disseminated intravascular coagulation and outcomes
por: Wada, Takeshi, et al.
Publicado: (2022)

Editorial: Macrophage immunity and metabolism in cancer: Novel diagnostic and therapeutic strategies
por: Leavenworth, Jianmei W., et al.
Publicado: (2022)

Effects of Neutrophil Extracellular Traps in Patients With Septic Coagulopathy and Their Interaction With Autophagy
por: Mao, Jia-Yu, et al.
Publicado: (2021)

Thrombosis and Coagulopathy in COVID-19
por: Gómez-Mesa, Juan Esteban, et al.
Publicado: (2021)

Reply to: COVID-19 and Coagulopathy
por: Rodríguez, Cristina, et al.
Publicado: (2021)

Studying the coagulopathy of COVID-19
por: Spyropoulos, Alex C, et al.
Publicado: (2022)

Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy
por: Balagholi, Sahar, et al.
Publicado: (2020)

Pathophysiology of Coagulopathy Induced by Traumatic Brain Injury Is Identical to That of Disseminated Intravascular Coagulation With Hyperfibrinolysis
por: Wada, Takeshi, et al.
Publicado: (2021)

Endothelial glycocalyx injury is involved in heatstroke-associated coagulopathy and protected by N-acetylcysteine
por: Peng, Na, et al.
Publicado: (2023)

Identification of 3 key genes as novel diagnostic and therapeutic targets for OA and COVID-19
por: Zhang, Yiwei, et al.
Publicado: (2023)

Antithrombin as Therapeutic Intervention against Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation: Lessons Learned from COVID-19-Associated Coagulopathy
por: Wiedermann, Christian J.
Publicado: (2022)

Progressive COVID-19-Associated Coagulopathy Despite Treatment with Therapeutic Anticoagulation and Thrombolysis
por: Aribawa, I. Gusti Ngurah Mahaalit, et al.
Publicado: (2021)

Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19
por: Qin, Zhen, et al.
Publicado: (2021)

Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies
por: Abusukhun, Murad, et al.
Publicado: (2021)

Traumatized triad of complementopathy, endotheliopathy, and coagulopathy ˗ Impact on clinical outcomes in severe polytrauma patients
por: Yang, Zhangsheng, et al.
Publicado: (2022)

Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia
por: Zhao, Shixiang, et al.
Publicado: (2023)

COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge
por: Furlan, Anna, et al.
Publicado: (2021)

Diagnostic and prognostic value of Sepsis-Induced coagulopathy and International Society on Thrombosis and Hemostasis scoring systems in COVID-19-associated disseminated intravascular coagulopathy
por: Hosseini, Sayyideh Forough, et al.
Publicado: (2021)

COVID-19 : coagulopathie et thrombose
por: Tazi Mezalek, Z.
Publicado: (2021)

Curcumin and Coagulopathy in the COVID19 Era
por: Suresh, Padmanaban S.
Publicado: (2020)

COVID-19 coagulopathy, thrombosis, and bleeding
por: Chan, Noel C., et al.
Publicado: (2020)

The unique characteristics of COVID-19 coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2020)

The coagulopathy, endotheliopathy, and vasculitis of COVID-19
por: Iba, Toshiaki, et al.
Publicado: (2020)

COVID-19 Related Arterial Coagulopathy
por: Singh, Gagandeep, et al.
Publicado: (2020)

COVID-19 coagulopathy: an evolving story
por: The Lancet Haematology
Publicado: (2020)

COVID-19 coagulopathy and antiphospholipid syndrome
por: Serrano, Manuel, et al.
Publicado: (2022)

Understanding COVID-19-associated coagulopathy
por: Conway, Edward M., et al.
Publicado: (2022)

COVID‐19 and acute coagulopathy in pregnancy
por: Vlachodimitropoulou Koumoutsea, Evangelia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_icpudtjs5isk81nnf31it1psk6